NCT07379021 Mindfulness-Based Emotion Regulation Training for Hospitalized Children
| NCT ID | NCT07379021 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ataturk University |
| Condition | Fear |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2025-12-26 |
| Primary Completion | 2026-12-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2025-12-26 with a primary completion date of 2026-12-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hospitalization and medical procedures are a significant source of stress and anxiety for school-age children aged 7-11, who, due to their cognitive development, can perceive events but lack the capacity to cope effectively. The main objective of this project is to examine the effect of Mindfulness-Based Emotion Regulation Training, which will be applied to children aged 7-11 hospitalized in the pediatric clinic, on developing children's emotion regulation skills and reducing their fear levels related to the hospital. The research is a randomized controlled trial to be conducted between April 2026 and April 2027. Data will be collected using the "Child and Parent Introduction Form," the "Emotion Regulation Scale for Children and Adolescents," and the "Medical Procedure Fear Scale." While distraction techniques frequently used in the literature offer a quick and effective solution at the time of the procedure, this project differs in that it aims to provide children with sustainable emotion regulation skills that they can use not only at that moment but also in later stages of the illness and in future life events. As a result of the project, it is expected that the implemented training will increase adaptive emotion regulation strategies in children, significantly reduce medical fear and anxiety, and provide an evidence-based nursing intervention that will facilitate children's compliance with treatment.
Eligibility Criteria
Inclusion Criteria: * Be aged between 7 and 11 years old, * Have a planned hospital stay of at least four days, * Be able to speak and understand Turkish, * Be able to read and write (to complete questionnaires), * The child and parent must be willing to participate in the study. Exclusion Criteria: * The child has a hearing/speech problem that prevents them from communicating, * The child has severe pain or acute respiratory distress that prevents them from participating, * The child has a known psychiatric diagnosis, * The child has previously received similar mindfulness training
Frequently Asked Questions
Who can join the NCT07379021 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 11 Years, studying Fear. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07379021 currently recruiting?
Yes, NCT07379021 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ataturk University to inquire about joining.
Where is the NCT07379021 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT07379021 clinical trial?
NCT07379021 is sponsored by Ataturk University. The trial plans to enroll 54 participants.